日本語View as Markdown

[Research progress of hydrogen-rich saline for eye diseases].

水素富化生理食塩水の眼疾患への応用に関する研究動向

review injection / infusion not assessed

Abstract

Molecular hydrogen has attracted considerable attention as an antioxidant agent with a favorable safety profile, as it does not interfere with essential metabolic redox processes or disrupt reactive oxygen species involved in cellular signaling. Evidence from biological and medical research indicates beneficial outcomes across multiple organ systems, including the nervous, digestive, and respiratory systems, as well as the heart and kidneys. However, investigations into its effects on ocular conditions remain sparse. This review consolidates findings from domestic and international literature to outline the current state of research on hydrogen-rich water in the context of eye diseases, highlighting areas where evidence is emerging and where further study is warranted.

Mechanism

Hydrogen acts as a selective antioxidant, neutralizing excess reactive oxygen species without disrupting those required for normal cellular signaling, thereby potentially protecting ocular tissues from oxidative damage.

Bibliographic

Authors
Chen X, Zhou XQ, Wei RL
Journal
Zhonghua Yan Ke Za Zhi
Year
2018 (2018-08-11)
PMID
30107657
DOI
10.3760/cma.j.issn.0412-4081.2018.08.015

Tags

Disease:網膜疾患 Delivery:点滴投与 Mechanism:抗酸化酵素 ヒドロキシルラジカル消去 炎症抑制 酸化ストレス 活性酸素種

Delivery context

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

Safety notes

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 30107657. https://h2-papers.org/en/papers/30107657
Source: PubMed PMID 30107657